PrecisionFDA is an initiative by the U.S. Food and Drug Administration (FDA) aimed at advancing the science of genomics and improving the use of next-generation sequencing (NGS) in clinical and regulatory settings. Launched in 2015, PrecisionFDA serves as a collaborative platform where researchers, regulatory professionals, and other stakeholders can share and evaluate genomic data, tools, and methods.
New to topics? Read the docs here!